Evaxion AS (EVAX)
3.13
+0.03
(+0.97%)
USD |
NASDAQ |
Sep 11, 16:00
3.17
+0.04
(+1.28%)
After-Hours: 20:00
Evaxion Price : 3.13 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.17 | 3.200 | 3.10 | 3.13 | 30259.00 |
| Sep 10, 2026 | 3.29 | 3.29 | 3.05 | 3.10 | 87194.00 |
| Sep 09, 2026 | 3.22 | 3.33 | 3.21 | 3.29 | 61376.00 |
| Sep 08, 2026 | 3.12 | 3.305 | 3.10 | 3.17 | 63850.00 |
| Sep 04, 2026 | 3.12 | 3.16 | 3.06 | 3.12 | 38328.00 |
| Sep 03, 2026 | 3.10 | 3.15 | 3.067 | 3.08 | 39611.00 |
| Sep 02, 2026 | 3.00 | 3.190 | 2.99 | 3.07 | 60661.00 |
| Sep 01, 2026 | 2.98 | 3.040 | 2.92 | 2.98 | 63035.00 |
| Aug 31, 2026 | 3.07 | 3.07 | 2.90 | 3.00 | 102016.0 |
| Aug 28, 2026 | 3.15 | 3.16 | 3.01 | 3.01 | 123526.0 |
| Aug 27, 2026 | 3.29 | 3.30 | 3.14 | 3.15 | 74054.00 |
| Aug 26, 2026 | 3.32 | 3.40 | 3.18 | 3.24 | 112117.0 |
| Aug 25, 2026 | 3.41 | 3.55 | 3.340 | 3.35 | 149883.0 |
| Aug 24, 2026 | 3.33 | 3.46 | 3.17 | 3.40 | 183587.0 |
| Aug 21, 2026 | 3.37 | 3.45 | 3.12 | 3.31 | 540831.0 |
| Aug 20, 2026 | 3.40 | 3.64 | 2.95 | 3.28 | 3.595M |
| Aug 19, 2026 | 3.03 | 3.37 | 2.83 | 3.15 | 6.362M |
| Aug 18, 2026 | 3.09 | 3.177 | 3.00 | 3.15 | 11133.00 |
| Aug 17, 2026 | 3.35 | 3.40 | 3.058 | 3.13 | 18329.00 |
| Aug 14, 2026 | 3.29 | 3.34 | 3.16 | 3.34 | 19841.00 |
| Aug 13, 2026 | 3.10 | 3.38 | 3.10 | 3.211 | 12591.00 |
| Aug 12, 2026 | 3.005 | 3.16 | 2.97 | 3.07 | 21475.00 |
| Aug 11, 2026 | 3.07 | 3.150 | 2.97 | 3.06 | 17109.00 |
| Aug 10, 2026 | 3.10 | 3.32 | 3.03 | 3.05 | 35052.00 |
| Aug 07, 2026 | 3.100 | 3.10 | 2.97 | 3.10 | 7962.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.88 |
| DBV Technologies SA | 11.85 |
| Cellectis SA | 3.10 |
| Akari Therapeutics Plc | 11.30 |
| Ascendis Pharma A/S | 263.52 |
Price Related Metrics
| PS Ratio | 3.112 |
| Price to Book Value | 2.739 |
| Earnings Yield | -33.66% |
| Market Cap | 26.10M |